Presentation is loading. Please wait.

Presentation is loading. Please wait.

Incidence of in-hospital mortality rates are lower in rapid correction rate group versus slow correction rate group but not significantly different by.

Published byΘυώνη Παπαδόπουλος Modified over 5 years ago

Similar presentations

Presentation on theme: "Incidence of in-hospital mortality rates are lower in rapid correction rate group versus slow correction rate group but not significantly different by."— Presentation transcript:

1 Incidence of in-hospital mortality rates are lower in rapid correction rate group versus slow correction rate group but not significantly different by various cut-offs of correction rates Figure 2A and 2B represents admission and hospital-acquired hypernatr... Incidence of in-hospital mortality rates are lower in rapid correction rate group versus slow correction rate group but not significantly different by various cut-offs of correction rates Figure 2A and 2B represents admission and hospital-acquired hypernatremia patients respectively. In-hospital mortality proportions in patients with (A) admission and (B) hospital-acquired hypernatremia. Kinsuk Chauhan et al. CJASN 2019;14: ©2019 by American Society of Nephrology

Download ppt "Incidence of in-hospital mortality rates are lower in rapid correction rate group versus slow correction rate group but not significantly different by."

Similar presentations

Mortality HRs for dialysis modality (PD versus HD) in 23,718 incident dialysis patients using a marginal structural model (MSM) taking into account changes.

Mortality HRs for dialysis modality (PD versus HD) in 23,718 incident dialysis patients using a marginal structural model (MSM) taking into account changes.
Among Medicare beneficiaries >65 years old with a index hospitalization at the time of dialysis initiation, use of post-acute SNF care was common. Among.

Among Medicare beneficiaries >65 years old with a index hospitalization at the time of dialysis initiation, use of post-acute SNF care was common. Among.
Suggested approach to patients with dabigatran-associated bleeding

Suggested approach to patients with dabigatran-associated bleeding
Positive interactions between the basic and translational research, clinical research, patient care, and training components of an academic dialysis access.

Positive interactions between the basic and translational research, clinical research, patient care, and training components of an academic dialysis access.
Figure 1.17 of the 2016 US Renal Data System Annual Data Report, Volume 2, chapter 1 showing the trends in the number of patients with incident ESRD (in.

Figure 1.17 of the 2016 US Renal Data System Annual Data Report, Volume 2, chapter 1 showing the trends in the number of patients with incident ESRD (in.
Probability of cumulative incidence of ESRD, disease-related death, or death from other cause for the entire cohort. Probability of cumulative incidence.

Probability of cumulative incidence of ESRD, disease-related death, or death from other cause for the entire cohort. Probability of cumulative incidence.
The incidence of all cause graft failure, and death with a functioning graft was higher in patients who received a DCD donor transplant with total donor.

The incidence of all cause graft failure, and death with a functioning graft was higher in patients who received a DCD donor transplant with total donor.
Patterns of mortal risk among eKt/V quintiles in the HEMO study for (A) 1 yr of follow-up and (B) after 1 yr. Patterns of mortal risk among eKt/V quintiles.

Patterns of mortal risk among eKt/V quintiles in the HEMO study for (A) 1 yr of follow-up and (B) after 1 yr. Patterns of mortal risk among eKt/V quintiles.
Adjusted rate ratios of hospital days and admissions for blacks and Hispanics compared with whites by age group. Adjusted rate ratios of hospital days.

Adjusted rate ratios of hospital days and admissions for blacks and Hispanics compared with whites by age group. Adjusted rate ratios of hospital days.
(A) Comparison of V, however estimated, to itself and to a transformation of V, Vt = 3.27 × V2/3 (see reference 42). (A) Comparison of V, however estimated,

(A) Comparison of V, however estimated, to itself and to a transformation of V, Vt = 3.27 × V2/3 (see reference 42). (A) Comparison of V, however estimated,
Differing renal outcomes associated with AKI electronic alerts for clinical location of AKI subsets. Differing renal outcomes associated with AKI electronic.

Differing renal outcomes associated with AKI electronic alerts for clinical location of AKI subsets. Differing renal outcomes associated with AKI electronic.
Parathyroid hormone (PTH) levels by Dialysis Outcomes and Practice Patterns Study (DOPPS) phase and selected patient characteristics. Parathyroid hormone.

Parathyroid hormone (PTH) levels by Dialysis Outcomes and Practice Patterns Study (DOPPS) phase and selected patient characteristics. Parathyroid hormone.
Patient disposition. Patient disposition. AE, adverse event. *One patient died during the follow-up period. ^Four of the 12 discontinuations of treatment.

Patient disposition. Patient disposition. AE, adverse event. *One patient died during the follow-up period. ^Four of the 12 discontinuations of treatment.
Catherine M. Pound et al. Hospital Pediatrics 2017;7:

Catherine M. Pound et al. Hospital Pediatrics 2017;7:
Three-year cumulative incidence of a gout diagnosis presented by level of kidney function and sex. Three-year cumulative incidence of a gout diagnosis.

Three-year cumulative incidence of a gout diagnosis presented by level of kidney function and sex. Three-year cumulative incidence of a gout diagnosis.
Thirty-day survival curves for the rapid versus slow correction rate groups are not significantly different. Thirty-day survival curves for the rapid versus.

Thirty-day survival curves for the rapid versus slow correction rate groups are not significantly different. Thirty-day survival curves for the rapid versus.
Kaplan–Meier curve for technique survival censored for death, transplantation, and program exit for patient choice for all individuals commencing home.

Kaplan–Meier curve for technique survival censored for death, transplantation, and program exit for patient choice for all individuals commencing home.
(A) Mean (SD) serum continuous erythropoietin receptor activator (C. E

(A) Mean (SD) serum continuous erythropoietin receptor activator (C. E
Representative polyacrylamide/6% urea gels that demonstrate transferrin saturation (TSAT) for (A) a patient who was given the low-dosage (1.5 mg/kg) infusion.

Representative polyacrylamide/6% urea gels that demonstrate transferrin saturation (TSAT) for (A) a patient who was given the low-dosage (1.5 mg/kg) infusion.
Seven-year cumulative incidence of ESRD according to baseline creatinine clearance (Ccr) and result of urine test for proteinuria (19). Seven-year cumulative.

Seven-year cumulative incidence of ESRD according to baseline creatinine clearance (Ccr) and result of urine test for proteinuria (19). Seven-year cumulative.

Similar presentations

Ads by Google